• Product NameEliglustat
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityEliglustat (Tartrate) inhibits?glucosylceramide synthase(GCS),thus reducing the load of glucosylceramide influx into the lysosome.
• Target NameTransferase inhibitor
• CAS No. 491833-29-5
• Calculated MW 404.54
• Formulation C23H36N2O4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Metabolism
  SMILES:CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O
  Pathways:Metabolism
  Receptor:glucosylceramide synthase
  Boling pt:
  Melting pt:
  Solubility:DMSO: 80 mg/mL (197.75 mM);Ethanol: 80 mg/mL (197.75 mM)
  Appearance:Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Shayman JA. Drugs Future. 2010 Aug 1;35(8):613-620.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting